For use in healthy swine as an aid in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by PCV2. Efficacy for at least 20 weeks following completion of vaccination has been demonstrated. In addition, Circumvent PCV-M G2 has a label claim for an aid in the reduction of Mycoplasma hyopneumoniae.